Phl0x Pharma Limited

Phl0x Pharma Limited - chemicals in Hyderabad., Telangana, India. FY 2026 financials and compliance.
CIN U24230TG1995PLC021729 Incorporated 15 September 1995 ROC Hyderabad HQ Hyderabad., Telangana, India
Struck Off Public Limited Company chemicals
Data last updated
Revenue · Latest
-
Latest filing
EBITDA · Latest
*****
In full report
Net profit · Latest
*****
In full report
Authorised capital
₹60 Lakh
Registered with MCA
Paid-up capital
₹5.07 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
31 yrs
Est. 1995
Last financials
Mar 2008
Balance sheet date

About Phl0x Pharma Limited

Data last updated: 24 July 2025

Phl0x Pharma Limited was a public limited company based in Hyderabad., Telangana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It specialised in speciality chemicals, a part of the broader chemicals sector. Incorporated on 15 September 1995.

Registered with ROC Hyderabad under CIN U24230TG1995PLC021729.

Capital: an authorised share capital of ₹60 Lakh and a paid-up capital of ₹5.07 Lakh. It was led by directors including Majgaonkar Deepak Manasi and Deepak Vaman Majgaonkar.

Last AGM: 30 September 2008. Financial statements filed for year ended 31 March 2008. Office: C – 9 Madhura Nagar Hyderabad., Telangana, India – 500039.

The company is no longer operational and has been struck off from the Register of Companies, typically due to non-filing of annual returns or failure to commence business. Entering into any agreement with a struck-off entity carries significant legal and financial risk.

Company Details of Phl0x Pharma Limited
CIN U24230TG1995PLC021729
Registration Number 021729
Incorporation Date 15 September 1995
ROC Hyderabad
Listing Status Unlisted
Company Status Struck Off
Date of Last AGM 30 September 2008
Date of Balance Sheet 31 March 2008
Key People
Majgaonkar Deepak Manasi Director Deepak Vaman Majgaonkar Director Jyothi Ganti Director
Contact Details
  • Email
    **************
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    C – 9 Madhura Nagar Hyderabad., Telangana, India – 500039
  • Industry
    Chemicals, Other Chemical Product, Manufacturing
Company report
Phl0x Pharma Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Phl0x Pharma Limited report

Financials, compliance, directors, charges, ownership and filings for Phl0x Pharma Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Phl0x Pharma Limited

Phl0x Pharma Limited has one previous CIN (Corporate Identification Number): U24230AP1995PLC021729. The current CIN is U24230TG1995PLC021729, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24230TG1995PLC021729 Current
U24230AP1995PLC021729 Previous

Board of Directors of Phl0x Pharma Limited

Phl0x Pharma Limited is governed by 3 directors who oversee the company's operations and strategic decisions.

Directors (as last reported)
Name Designation Appointment Date Tenure Status
Majgaonkar Deepak Manasi Director 12 Oct 1998 27 Years 8 Months As last reported
Deepak Vaman Majgaonkar Director 15 Sep 1995 30 Years 9 Months As last reported
Jyothi Ganti Director 12 Oct 1998 27 Years 8 Months As last reported
View all directors

Financials of Phl0x Pharma Limited FY 2008 filings available

Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Charges & Borrowings Phl0x Pharma Limited

Phl0x Pharma Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Phl0x Pharma Limited

View historical data on people associated with Phl0x Pharma Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Phl0x Pharma Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Phl0x Pharma Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Phl0x Pharma Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Phl0x Pharma Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Phl0x Pharma Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Phl0x Pharma Limited

MSME Payment Delays by Phl0x Pharma Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Phl0x Pharma Limited

Subsidiaries & Group Companies of Phl0x Pharma Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Phl0x Pharma Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Phl0x Pharma Limited

MCA Filings & Documents of Phl0x Pharma Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Phl0x Pharma Limited

Activity
30 Sep 2008
Phl0X Pharma Limited last Annual general meeting of members was held on 30 Sep 2008 as per latest MCA records.
Activity
31 Mar 2008
Phl0X Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2008 with Roc Hyderabad.
Directors
12 Oct 1998
Majgaonkar Deepak Manasi was appointed as a Director on 12 Oct 1998 & has been associated with this company since 27 years 8 months.
Directors
12 Oct 1998
Jyothi Ganti was appointed as a Director on 12 Oct 1998 & has been associated with this company since 27 years 8 months.
Directors
15 Sep 1995
Deepak Vaman Majgaonkar was appointed as a Director on 15 Sep 1995 & has been associated with this company since 30 years 9 months.
Activity
15 Sep 1995
Phl0X Pharma Limited was registered on 15 Sep 1995 with Roc Hyderabad & aged 30 years 9 months as per MCA records.

Frequently Asked Questions about Phl0x Pharma Limited

Phl0x Pharma Limited has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.

Phl0x Pharma Limited is a struck-off public limited company in the chemicals sector based in Hyderabad, Telangana, India. It was incorporated on 15 September 1995 and is registered under CIN U24230TG1995PLC021729. The company has been struck off by the Registrar of Companies and is no longer operational.

The current directors of Phl0x Pharma Limited are:

The CIN (Corporate Identification Number) of Phl0x Pharma Limited is U24230TG1995PLC021729. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The primary industry of Phl0x Pharma Limited is chemicals. The company specifically operates in other chemical product. The company was active in this sector before being struck off.

The company has its registered office at C – 9 Madhura Nagar Hyderabad., Telangana, India – 500039.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available